SG Americas Securities
SCPH

SG Americas Securities’s scPharmaceuticals SCPH Stock Holding History

SG Americas Securities’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,761
Closed -$36K – 3507
2025
Q1 		$36K Sell
13,761
-4,797
-26% -$15.6K ﹤0.01% 3307
2024
Q4 		$66K Buy
+18,558
New +$71.1K ﹤0.01% 2855
2019
Q3 		– Sell
-12,877
Closed -$41K – 3187
2019
Q2 		$41K Sell
12,877
-4,116
-24% -$13.5K ﹤0.01% 2943
2019
Q1 		$51K Buy
+16,993
New +$58.4K ﹤0.01% 3188

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SG Americas Securities's SCPH Position: Q2 2025 in Review

SG Americas Securities sold out of scPharmaceuticals (SCPH) in Q2 2025, closing a stake of 13,761 shares — an estimated $36K sold.

SG Americas Securities first reported a position in SCPH in Q1 2019 and held it in 4 quarters. The position peaked at $66K in Q4 2024. 97 funds tracked by Wall St. Rank hold SCPH as of Q2 2025.

  • SG Americas Securities reported no remaining scPharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 13,761 scPharmaceuticals shares in Q2 2025, an estimated $36K.
  • SG Americas Securities first reported a position in scPharmaceuticals in Q1 2019 and held it in 4 quarters.
  • SG Americas Securities's scPharmaceuticals position peaked at $66K in Q4 2024.
  • 97 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.